Studies find Omicron related hospitalisations lower in severity than Delta and Pfizer-BioNTech COVID vaccine remains effective in preventing hospitalisations
Adult hospitalisations from Omicron-related SARS-CoV-2 (COVID-19) were less severe than Delta and the Pfizer-BioNTech vaccine (also known as Comirnaty and BNT162b2*) remains effective in preventing not only hospitalisation, but severe patient outcomes associated with COVID-19, two new research studies have found.
Source: University of Bristol news - Category: Universities & Medical Training Tags: Health, International, Research; Faculty of Health Sciences, Institutes, Institutes, Elizabeth Blackwell; Press Release Source Type: news
More News: Covid Vaccine | COVID-19 | Pfizer | SARS | Study | Universities & Medical Training | Vaccines